Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] NLMUID: 8212398"" wg kryterium: JN


Tytuł :
[Autologous stem cell transplantation improve the survival of newly diagnosed multiple myeloma patients].
Autorzy :
Geng CY; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Yang GZ; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Wang GR; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Wang HJ; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Zhou HX; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Zhang ZY; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Jian Y; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Chen WM; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 390-395.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*
Aged ; Disease-Free Survival ; Humans ; Retrospective Studies ; Transplantation, Autologous ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[Treatment of relapsed and refractory EZB/C3 subtype DLBCL with chidamide in combination of R2-CHOP: a case report].
Autorzy :
Yang L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhang W; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhang ML; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Shen KF; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Wang JC; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Guan YQ; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Cai HD; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Bao YH; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Xiao M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhou JF; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zheng M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 436-437.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Aminopyridines*/therapeutic use
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Benzamides/therapeutic use ; Humans ; Rituximab/therapeutic use
Czasopismo naukowe
Tytuł :
[Efficacy and prognostic analysis of frontline Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone regimens (VR-CAP) for patients with mantle cell lymphoma].
Autorzy :
Cao YW; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Zheng Z; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Xu PP; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Cheng S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Wang L; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Qian Y; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Zhao WL; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 415-419.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma, Mantle-Cell*/drug therapy
Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bortezomib/therapeutic use ; Cyclophosphamide/therapeutic use ; Doxorubicin/therapeutic use ; Humans ; Prednisone/therapeutic use ; Prognosis ; Rituximab/therapeutic use ; Vincristine/therapeutic use
Czasopismo naukowe
Tytuł :
[Chinese guidelines of autologous stem cell transplantation for multiple myeloma (2021)].
Corporate Authors :
Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association
Chinese Myeloma Committee-Chinese Hematology Association
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 353-357.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*/therapy
China ; Humans ; Stem Cell Transplantation ; Transplantation Conditioning ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
[The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients].
Autorzy :
Fang QY; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Hao QS; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Gong XY; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Wang J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Li QH; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Yuan T; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Tian Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Liu KQ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Li Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Liu YT; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Gong BF; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Wang Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Wei H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Zhou CL; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Lin D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Liu BC; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Wei SN; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Zhang GJ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Wang JX; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Mi YC; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 432-435.
Typ publikacji :
Journal Article
MeSH Terms :
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Adult ; Cell Cycle Proteins/genetics ; Cyclin-Dependent Kinase Inhibitor p16/genetics ; F-Box-WD Repeat-Containing Protein 7/genetics ; Humans ; Mutation ; Prognosis ; Receptor, Notch1/genetics ; T-Lymphocytes
Czasopismo naukowe
Tytuł :
[A comparative analysis of autologous hematopoietic stem cell transplantation and chemotherapy alone in the treatment of nodal peripheral T-cell lymphoma in complete remission].
Autorzy :
Jiao Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Liu W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Yi SH; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Liu HM; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Yu Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Huang WY; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Qiu LG; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Zou DH; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 428-431.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Lymphoma, T-Cell, Peripheral*/therapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Combined Modality Therapy ; Humans ; Remission Induction ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
[Expert consensus on the whole-process management model of lymphoma patients in China (2021)].
Corporate Authors :
Union for China Lymphoma Invesingators
Chinese Medical Doctor Association, Hematology Branch
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 364-368.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma*/therapy
China ; Consensus ; Humans
Czasopismo naukowe
Tytuł :
[ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease].
Autorzy :
Xue F; Insitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
Yang RC; Insitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 358-363.
Typ publikacji :
Journal Article
MeSH Terms :
von Willebrand Diseases*/diagnosis
Humans ; von Willebrand Factor
Czasopismo naukowe
Tytuł :
[Prognostic factors of cyclosporine A combined with danazol with or without thalidomide in myelodysplastic syndrome treatment with low-percentage bone marrow blasts].
Autorzy :
Zhang YD; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Xu ZF; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Qin TJ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Li B; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Qu SQ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Pan LJ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Jiao M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Xiao ZJ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 376-382.
Typ publikacji :
Journal Article
MeSH Terms :
Myelodysplastic Syndromes*
Thalidomide*
Bone Marrow ; Cyclosporine ; Danazol ; Humans ; Infant, Newborn ; Middle Aged ; Prognosis ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[Prognostic value of activated partial thromboplastin time and D-dimer in chronic lymphocytic leukemia].
Autorzy :
Mao J; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Pan BH; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Yin H; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Wu JZ; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Xia Y; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Wang L; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Li JY; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Xu W; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 425-427.
Typ publikacji :
Journal Article
MeSH Terms :
Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis
Fibrin Fibrinogen Degradation Products ; Humans ; Partial Thromboplastin Time ; Prognosis
Czasopismo naukowe
Tytuł :
[Clinical and prognostic values of TP53 mutation in patients with B-lineage acute lymphoblastic leukemia].
Autorzy :
Du YY; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Lyu KK; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Xu MM; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Yao WQ; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Kang HZ; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Han Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Tang XW; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Ma X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Wu XJ; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
He XF; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Wu DP; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Liu YJ; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 396-401.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Receptors, Chimeric Antigen*
Humans ; Mutation ; Prognosis ; Retrospective Studies ; Tumor Suppressor Protein p53
Czasopismo naukowe
Tytuł :
[Transcription factor EB related autophagy in the treatment of multiple myeloma and its mechanism].
Autorzy :
Zhang ZH; Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
Zhang RJ; Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
Han N; Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
Li C; Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
Wang LL; Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
Xing EH; Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
Gu CH; Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
Hao CL; Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 407-414.
Typ publikacji :
Journal Article
MeSH Terms :
Multiple Myeloma*
Apoptosis ; Autophagy ; Beclin-1 ; Bortezomib ; Cell Line, Tumor ; Cell Proliferation ; Humans
Czasopismo naukowe
Tytuł :
[Application of Bcl-2 inhibitor venetoclax in acute myeloid leukemia].
Autorzy :
Zhang Y; The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.
Jin J; The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 438-440.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents*/therapeutic use
Leukemia, Myeloid, Acute*/drug therapy
Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Humans ; Proto-Oncogene Proteins c-bcl-2 ; Sulfonamides/therapeutic use
Czasopismo naukowe
Tytuł :
[A physician-patient survey for primary immune thrombocytopenia: Chinese subgroup analysis of I-WISh International Survey].
Autorzy :
Wang RT; Department of Hematology, Qilu Hospital, Shandong University, Jinan 250012, China.
Liu XG; Department of Hematology, Qilu Hospital, Shandong University, Jinan 250012, China.
Hou Y; Department of Hematology, Qilu Hospital, Shandong University, Jinan 250012, China.
Hou M; Department of Hematology, Qilu Hospital, Shandong University, Jinan 250012, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 369-375.
Typ publikacji :
Journal Article
MeSH Terms :
Physicians*
Purpura, Thrombocytopenic, Idiopathic*
China ; Humans ; Quality of Life ; Receptors, Thrombopoietin ; Thrombopoietin
Czasopismo naukowe
Tytuł :
[Allogeneic donor-derived CD19 CAR-T therapy of relapsed B-cell acute lmphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
Autorzy :
Ma RZ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
He Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Yang DL; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Wei JL; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Pang AM; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Jiang EL; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Wang JX; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Han MZ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Zhang RL; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Feng SZ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 383-389.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Receptors, Chimeric Antigen*
Antigens, CD19 ; B-Lymphocytes ; Humans ; Immunotherapy, Adoptive
Czasopismo naukowe
Tytuł :
[Multiple myeloma with multiple extramedullary lesions of pancreas, stomach and skin: a case report].
Autorzy :
Wang T; Department of Oncology, The Second Hospital of Lanzhou University, Lanzhou 730000, China.
Xie J; Department of Oncology, The Second Hospital of Lanzhou University, Lanzhou 730000, China.
Song FX; Department of Oncology, The Second Hospital of Lanzhou University, Lanzhou 730000, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 437.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Multiple Myeloma*
Humans ; Pancreas ; Stomach
Czasopismo naukowe
Tytuł :
[Spectrum of gene mutations and clinical features in adult acute myeloid leukemia with normal karyotype].
Autorzy :
Huang AJ; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Gao L; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Ni X; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Hu XX; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Tang GS; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Cheng H; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Chen J; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Chen L; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Liu LX; Acornmed Biotechnology Co., Ltd. Beijing, 100176.
Wang CC; Acornmed Biotechnology Co., Ltd. Beijing, 100176.
Zhang WP; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Yang JM; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Wang JM; Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 May 14; Vol. 42 (5), pp. 420-424.
Typ publikacji :
Journal Article
MeSH Terms :
Leukemia, Myeloid, Acute*/genetics
Adult ; Humans ; Karyotype ; Mutation ; Prognosis
Czasopismo naukowe
Tytuł :
[Chinese consensus on the diagnosis and management of chronic graft-versus-host disease (2021)].
Corporate Authors :
Hematopoietic Stem Cell Application Group, Chinese Society of Hematology, Chinese Medical Association
China Association for the Prevention of Hematology Diseases
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 Apr 14; Vol. 42 (4), pp. 265-275.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*/diagnosis
Graft vs Host Disease*/therapy
Hematopoietic Stem Cell Transplantation*
China ; Chronic Disease ; Consensus ; Humans
Czasopismo naukowe
Tytuł :
[Expression of MMP-9 and microvessels in rat organs with chronic mountain sickness].
Autorzy :
Ma Y; Department of Hematology, Affiliated Hospital of Qinghai University, Xining 810000, China.
Zhu MM; Department of Hematology, Affiliated Hospital of Qinghai University, Xining 810000, China.
Yang M; Department of Hematology, Affiliated Hospital of Qinghai University, Xining 810000, China.
Luo W; Department of Hematology, Affiliated Hospital of Qinghai University, Xining 810000, China.
Ji LH; Department of Hematology, Affiliated Hospital of Qinghai University, Xining 810000, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 Apr 14; Vol. 42 (4), pp. 343-345.
Typ publikacji :
Journal Article
MeSH Terms :
Altitude Sickness*
Acute Disease ; Animals ; Chronic Disease ; Matrix Metalloproteinase 9 ; Microvessels ; Rats
Czasopismo naukowe
Tytuł :
[CART therapy followed by allo-HSCT for patients with B-cell acute lymphoblastic leukemia relapsing after the first hematopoietic stem cell transplantation].
Autorzy :
Cao XY; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Qiu LY; Cryopreservation Department, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Zhang JP; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Xiong M; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Zhao YL; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Lu Y; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Zhou JR; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Wei ZJ; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Sun RJ; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Liu DY; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Zhang X; Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Yang JF; Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Lu PH; Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 Apr 14; Vol. 42 (4), pp. 318-323.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
B-Lymphocytes ; Female ; Humans ; Male ; Recurrence ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies